https://www.selleckchem.com/pr....oducts/3-methyladeni
To clarify the epidemiological, clinical, and therapeutic features of patients with severe COVID-19. In this study, we enrolled 681 patients with confirmed cases of severe COVID-19. The epidemiological, demographic, clinical, laboratory, treatment, and outcome data were collected. The median age of the study participants was 65years, 53.2% were male, and 104 (15.3%) died. Age, Neutrophil-To-Lymphocyte Ratio (NLR), acute myocardial injury, and levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), and CD3 T cells counts
Like
Comment
Share
